4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000218
EVP, Chief Business Officer sold 5,635 shares at $80.16 ($451,699)
- EVP, Chief Business Officer acquired 5,635 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,866 | $56.78 | $219,511 | 8,535 | I |
| 2026-06-26 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,769 | $32.60 | $57,669 | 10,304 | I |
| 2026-06-26 | Sale : show line 3 in the form 10b5-1 | −5,635 | $80.16 | $451,699 | 4,669 | I |
| Open-market sales · 5,635 sh · avg $80.16 · $451,699 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-26 | Exercise or conversion : show line 4 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,769 | 0 | I |
| 2026-06-26 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −3,866 | 0 | I |
Loading xslF345X06/edgardoc.xml…